Work

Retrospective Evaluation of Infusion Tolerability: Ublituximab Real-world Observational Survey (ENAMOR) (P7-1.015)

Year: 2025

Type: article

Study design: Observational Study

Source: Neurology

DOI: 10.1212/wnl.0000000000212153

Authors: Edward Fox, Peter Sportelli, Hari Miskin, Chris Garner

Institution: TG Therapeutics, Inc. (United States)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409227252

FWCI: 0.541

Cites:

Cited by: 1

Related to: 10